Imaging Complex Molecular Signatures in Cancer
Imaging Complex Molecular Signatures in Cancer
批准号:
7318654
负责人:
ANN-MARIE BROOME
金额:
$9.42万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-13 至 2012-07-31
关键词:
AnimalsAntibodiesBindingBiologicalBiological MarkersCell Surface ProteinsCell surfaceCellsChimeric ProteinsClinicComplementComplexDataDetectionDevelopmentDevelopment PlansDiagnosticDiseaseDisease MarkerEngineeringEnzymesFacility Construction Funding CategoryFacultyGene ExpressionGenesGoalsHalf-LifeImageImaging technologyIn SituIn VitroInvasiveKnowledgeLaboratoriesLearningLigandsMalignant NeoplasmsMammalian CellMeasuresModalityMolecularMolecular ProfilingMolecular TargetNatural regenerationNormal tissue morphologyPhysiologyProteinsReportingResearchResearch PersonnelSensitivity and SpecificitySignal TransductionSupervisionSurfaceTechniquesTechnologyTestingTimeTissuesTumor MarkersUniversitiesantibody conjugatecareercellular targetingdesigndisease classificationexperienceimaging probein vivomolecular imagingnovelprogramsreceptorresearch studyskillstool developmenttumor
中文摘要
描述(由申请人提供):
近年来,分子成像已成功地用作对哺乳动物生理学的各个方面进行成像的技术。然而,使用这些非侵入性方式可以获得的信息是有限的,因为它依赖于单基因标记物的表达和成像。虽然这些信息很有用,但可能会产生误导。例如,在疾病组织中过表达的标志物也以时空方式在正常组织中表达,使得在诊断环境中解释结果可能困难。几项研究已经证明,通过测量基因表达中多种疾病相关变化的表达,对疾病的鉴定和分子分类具有高度的灵敏度和特异性。因此,这些基因标志物中的一种以上的同时过表达更能预测疾病状态。到目前为止,分子成像无法一次成像一个以上的标记物,需要同时使用不同的成像技术,或者需要快速连续成像具有短生物半衰期的不同探针。这项研究的目标是开发一种成像模式,允许同时检测和成像多种过度表达的癌症疾病靶点。在这里提出的实验中,我们将尝试将这些结构域与三种不同的配体中的每一种结合,以通过原位酶重建同时靶向和成像三种不同的分子成像靶标。该成像范例的应用将在体内用携带表达反式互补所需的生物标志物的子集或全部的肿瘤的动物进行。拟议的职业发展计划将为候选人提供受保护的时间,通过学习新的实验室技术,选择性的教学课程,并扩大她的知识和经验,在实验室和临床实验的实际进行,进一步发展她的研究技能,在经验丰富的赞助商的密切监督下,从顾问,合作者,同事和大学内的其他教师的投入。
英文摘要
DESCRIPTION (provided by applicant):
Molecular imaging has successfully been utilized in the recent past as a technology for imaging various aspects of mammalian physiology. However, the information that can be obtained using these non-invasive modalities is limited since it relies on the expression and imaging of single gene markers. While this information is useful, it can be misleading. For example, markers over-expressed in diseases tissues are also expressed in normal tissues in a spatio-temporal manner making interpretation of the results in a diagnostic setting potentially difficult. Several studies have demonstrated a high degree of both sensitivity and specificity for the identification and molecular classification of diseases by measuring the expression of multiple disease-associated changes in gene expression. The simultaneous over-expression of more than one of these gene markers is, therefore, more predictive of the disease state. Until now, molecular imaging was unable to image more than one marker at a time, requiring either different imaging technologies to be utilized simultaneously or requiring different probes with short biological half-lives to be imaged in rapid succession. The goal of the proposed study is to develop an imaging paradigm that will allow the detection and imaging of multiple over-expressed cancer disease targets at the same time. In the experiments proposed here we will attempt to conjugate these domains to each of three different ligands to simultaneously target and image, via enzyme re-construction in situ, three different molecular imaging targets. Application of this imaging paradigm will be conducted in vivo with animals bearing tumors that express either a subset or all of the biomarkers required for trans complementation. The proposed career development plan will offer the candidate protected time to further develop her research skills by learning new laboratory techniques, taking selective didactic coursework, and expanding her knowledge and experience in the practical conduct of experimentation both in the laboratory and in the clinic under the close supervision of experienced sponsors with input from consultants, collaborators, colleagues, and other faculty within the University.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanotherapeutic Delivery of Resveratrol Analogs as a Pre-Treatment of Allografts in Solid Organ Transplantation
-
批准号:9034163
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2016
-
负责人:ANN-MARIE BROOME
-
依托单位:
Nanotherapeutic Delivery of Resveratrol Analogs as a Pre-Treatment of Allografts in Solid Organ Transplantation
-
批准号:9306943
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2016
-
负责人:ANN-MARIE BROOME
-
依托单位:
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain Cancer
-
批准号:8542845
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2010
-
负责人:ANN-MARIE BROOME
-
依托单位:
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain Cancer
-
批准号:8050347
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2010
-
负责人:ANN-MARIE BROOME
-
依托单位:
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain Cancer
-
批准号:8665627
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2010
-
负责人:ANN-MARIE BROOME
-
依托单位:
Imaging Complex Molecular Signatures in Cancer
-
批准号:8120244
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2007
-
负责人:ANN-MARIE BROOME
-
依托单位:
Imaging Complex Molecular Signatures in Cancer
-
批准号:7917430
-
项目类别:
-
资助金额:$11.0万
-
财政年份:2007
-
负责人:ANN-MARIE BROOME
-
依托单位:
Imaging Complex Molecular Signatures in Cancer
-
批准号:7656635
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2007
-
负责人:ANN-MARIE BROOME
-
依托单位:
TNF-alpha Regulation of S100A9 in Human Keratinocytes
-
批准号:7502417
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:ANN-MARIE BROOME
-
依托单位:
Imaging Complex Molecular Signatures in Cancer
-
批准号:7483008
-
项目类别:
-
资助金额:$9.61万
-
财政年份:2007
-
负责人:ANN-MARIE BROOME
-
依托单位:
海外基金